Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
Holding RNA?
Track your performance easily

Avidity Biosciences (RNA) Balance Sheet

663 Followers

Avidity Biosciences Balance Sheet

Avidity Biosciences's total assets for Q2 2024 were $1.35B, an increase of 41.61% from the previous quarter. RNA total liabilities were $126.39M for the fiscal quarter, a 4.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 628.55M$ 638.80M$ 427.58M$ 333.90M$ 96.91M
Total Liabilities
$ 127.79M$ 60.73M$ 46.15M$ 27.68M$ 162.26M
Total Equity Gross Minority
$ 500.73M$ 578.12M$ 381.43M$ 306.22M$ -65.36M
Total Capitalization
$ 506.98M$ 848.41M$ 466.52M$ 306.22M$ -63.59M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 938.00K$ 393.00K
Currency in USD

Avidity Biosciences Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis